… to modify or mediate their therapeutic effects. This review, … MSCs for the treatment of many
autoimmune and inflammatory … not respond to autologous BM-MSC infusion, and three of them …

… ) engineered to express human tumor necrosis factor (vMyx-… Virus therapy efficacy against
pre-seeded lung metastases … time, but sequential intravenous multi-dosing with naked virus …

… , many questions remained unanswered when this treatment … responding to induction
treatment with three infusions IFX of … associated with anti-tumor necrosis factor therapy in patients …

… to travel a long distance to receive intravenous infusions [2]. Patient … information and adverse
effects about anti-TNF treatment. … Many studies have shown that chronic disease treatment …

… parenterally, IFX via intravenous infusion, ADA, and golimumab … efficacy of anti-TNF therapy
is the use of biologic therapeutic … Many of these strategies are part of routine clinical practice …

… the treatment of IBD, and anti-tumor necrosis factor α (anti-TNF-α… a treatment effect with a
limited number of adverse events. … study received 300 mg of VDZ intravenously at week 0 and 2 …

… of a single cell dose, the idea that the full therapeutic effects of a … this effect to secretion of
the TSG-6 (tumor necrosis factor–… 29 suggest that intravenous infusion of MSCs is effective in …

… treatment efficacy across all mouse models treated with CYT-21625 compared to mice treated
with intravenous … a significantly lower tumor burden across multiple in vivo models using …

… inhibitors have demonstrated efficacy in inducing and … month or as intravenous infusions.
Similar to infliximab, the … those in multiple sclerosis following initiation of anti-TNF-α therapy [28, …

… and is a therapeutic target in many inflammatory disorders. The … Tumor necrosis factor (TNF)-targeted
therapies are … against TNF-α administered as an intravenous infusion. Etanercept, …